CDMO Strength Cerbios-Pharma is a Swiss-based leading CDMO offering end-to-end development and manufacturing for APIs, HPAPIs, payloads, ADCs, proteins, and antibodies, presenting a full-service partnership for biotech and pharma clients seeking integrated solution providers.

ADC Expertise With the Proveo ADC division delivering payload synthesis through conjugation and robust CMC/regulatory support, Cerbios can target biopharma partners developing antibody-drug conjugates needing scalable, compliant manufacturing and regulatory alignment.

HPAPI & Probiotics Strong capability in high-potency active ingredients and proprietary probiotic strains (Enterococcus faecium SF68) positions Cerbios to engage pharmaceutical and animal health customers seeking GMP HPAPI production and validated probiotic SKUs.

Swiss Precision Rooted in Swiss precision with facilities in Lugano and Couvet and part of the HAS Group, Cerbios offers trusted quality and integrated capabilities suitable for partners requiring robust supply continuity from development to commercial supply.

Growth Opportunities Revenue in the low-to-mid multi-million range and a broad portfolio including essential drug substances like Reduced Folates and Vitamin D analogues indicate potential cross-sell of API/HPAPI services, including animal health through the Cernivet line, to pharma, biotech, and animalhealth customers seeking end-to-end manufacturing support.